Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.64%
1,099.69
+6.95
+0.64%
1,092.741,095.951,103.321,094.72
SIXC
Communications
SIXC
Communications
SIXC
-0.45%
610.58
-2.78
-0.45%
613.36613.36613.36609.57
SIXE
Energy
SIXE
Energy
SIXE
-0.08%
1,175.90
-0.89
-0.08%
1,176.791,176.521,182.251,166.69
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,751.95
-3.59
-0.20%
1,755.541,759.231,766.301,749.83
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
635.15635.20636.89631.44
SIXR
Staples
SIXR
Staples
SIXR
+0.70%
853.95
+5.94
+0.70%
848.01852.52855.78850.17
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.44%
218.82
+0.96
+0.44%
217.86217.86219.52217.86
SIXT
Technology
SIXT
Technology
SIXT
+3.13%
3,524.42
+107.07
+3.13%
3,417.353,452.773,525.633,450.39
SIXU
Utilities
SIXU
Utilities
SIXU
-0.49%
908.87
-4.49
-0.49%
913.36915.10920.43904.94
SIXV
Health care
SIXV
Health care
SIXV
-0.95%
1,448.53
-13.85
-0.95%
1,462.381,461.131,464.531,447.19
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.58%
2,437.10
+13.96
+0.58%
2,423.142,428.712,448.692,424.63
NAGE:NASDAQ
Niagen Bioscience Inc
$4.13
-1.43%
(-0.060) 1D
May 8, 1:17:26 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NAGE...
Open
$4.23
High
$4.26
Low
$4.04
Mkt. cap
328.98M
Avg. vol.
762.84K
Volume
836.73K
52-wk high
$14.69
52-wk low
$4.04
Beta
2.17
Shares outstanding
79.64M
No. of employees
117
News stories
From sources across the web
Profile
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Wikipedia
About Niagen Bioscience Inc
CEO-
Employees117
Founded1999
HeadquartersLos Angeles, California, United States
SectorPersonal care products
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
31.12M
33.99M
33.84M
31.47M
Cost of goods sold
10.89M
12.06M
12.14M
11.50M
Cost of revenue
10.89M
12.06M
12.14M
11.50M
Research and development expenses
1.57M
1.80M
1.71M
1.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.47M
15.90M
17.89M
16.92M
Operating expense
17.04M
17.69M
19.60M
18.40M
Total operating expenses
27.93M
29.75M
31.74M
29.90M
Operating income
3.18M
4.24M
2.10M
1.58M
Other non operating income
-
-
-214.00K
-
EBT including unusual items
3.74M
4.80M
4.42M
6.74M
EBT excluding unusual items
3.74M
4.80M
2.44M
1.95M
Income tax expense
128.00K
222.00K
292.00K
417.00K
Effective tax rate
3.43%
4.62%
6.60%
6.19%
Other operating expenses
-
-
-
-
Net income
3.61M
4.58M
4.13M
6.32M
Net profit margin
11.60%
13.47%
12.21%
20.07%
Earnings per share
0.04
0.05
0.03
0.02
Interest and investment income
552.00K
564.00K
552.00K
-
Interest expense
-
-
-
375.00K
Net interest expenses
552.00K
564.00K
552.00K
375.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
3.38M
4.43M
2.30M
1.87M
Gain or loss from assets sale
-
-
-
-4.78M
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more